Shivom: core benefits of genomic data sequencing

Genomics analyzes all of the gene in our body and how they relate with each other in order to identify how our genes influence our development and health. Genome sequencing opens a door of possibilities whereby we can be able to receive precise diagnosis for a particular disease, targeted treatment for that disease as we know that not all medication work for everyone, our bodies react to certain drugs differently. Also genome sequencing will provide a better disease prediction and prevention approaches to specific illness which can work effectively in subgroups of patients based on their genetic make-up.

Initially, using genomic data to treat rare and chronic diseases was largely out of reach to most individuals and healthcare organizations but over the years the cost of genome sequencing has fallen significantly and Shivom aims to further subsidize this cost so that people from all works of life can key in to this technological breakthrough. People can in the comfort of their homes, sign up on the Shivom platform and have their test kit delivered to them at a fraction of the current cost of genome sequencing. This will in turn lead to a wider adoption of genome sequencing then we will be able to prepare ourselves for the best healthcare available through early intervention and a personalized approach to treatment.

Genomic data is highly sensitive as it indicates the current and future susceptibility to a specific disease of an individual and sometimes for his relatives as well. Therefore, genomic sequencing impose a greater privacy risk and therefore should be secured ultimately. To overcome this risk, Shivom is creating a decentralised Blockchain to make sure donor data is secured. Data stored using the Blockchain technology will at all times be secured.

Genome data donors own and have sole access to their data on the Shivom platform with the help of an encryption key. Data donors can choose to monetize their data by making their data available to pharmaceuticals, research organisations and other healthcare providers who wish to use the data for research and development programs at a cost. Donors in turn will receive OmiX tokens which is the key component that enables buying, trading, incentivization and other services on the Shivom platform for sharing their data. Donor data can only be accessed at the discretion of the donor, the donors will determine who will have access to their data.

In summary the Shivom platform is a dynamic ecosystem which will foster the timely identification and removal of potential health problems before they become serious.

Important links
Website: https://shivom.io/
Twitter: http://twitter.com/projectshivom
Telegram : https://t.me/projshivom
LinkedIN : http://linkedin.com/company/18302733/
Ann Thread: https://bitcointalk.org/index.php?topic=2365709
Whitepaper: https://shivom.io/files/Shivom-Executive-Summary.pdf
Medium : http://medium.com/@projectshivom

My Bitcointalk profile: https://bitcointalk.org/index.php?action=profile;u=1456130